Omicron, surely that’s enough

What have the scientific, pharmaceutical, and medical communities done to stifle SARS-CoV-2 infections? There are currently 18 advanced trials of different vaccines, 64 possible new treatments, and 23 potential or approved anti-viral drugs.

The mRNA vaccines from Pfizer and Moderna provide robust protection. (The mRNA technology is being expanded to HIV, malaria, and other diseases for which conventional vaccines have failed.) mRNA vaccines are expensive and need to be shipped frozen. Lower income countries require an effective vaccine that is inexpensive, survives at higher temperature and can be made locally.  Corbevax, created at Baylor College of Medicine, fits these criteria and is currently being made in hundreds of millions of doses in India. Other vaccines (Novovax) produce antibodies to viral proteins in addition to the Spike protein. The Novovax vaccine contains no genetic material.

Beyond vaccines there are 64 new treatments in development that block or slow infection or some of its consequences, like inflammation. Inflammation makes blood vessels leaky; defensive cells, which rush to the site of infection, squeeze out of the circulation, and infiltrate the lungs. They fill air sacs with dead neutrophils, eosinophils, and fluid, making the patient struggle to breathe.  In addition to the inflammatory reaction, when these cells die they release digestive enzymes that can do terrible damage to the lungs or other infected tissues. The use of steroids to inhibit inflammation was a critical early discovery. According to a review I read recently, it is still the best early intervention. Most viruses have means to inhibit a host’s immune system:  some inhibit interferon synthesis, a critical mobilizer of the immune response; SARS-CoV-2 inhibits the production of Natural Killer cells, which recognize infected lung cells and kill them. The more we know about these mechanisms the better off we will be.

There are currently 23 antivirals approved or in testing, including Merck’s Molnupiravir and Pfizer’s Paxlovid, but others have Emergency Use Authorizations as well. Paxlovid, if taken within 5 days of the onset of symptoms, blocks disease progression and keeps 90% of patients from hospitalization.  As a result, our hospitals are able to function, saving money, reducing misery and increasing morale.  Vaccinated and boosted people usually have a short illness unless they have other complications and may not need these therapeutics. But for those who do, or are unvaccinated the drugs are becoming available in pharmacies.

My friend, Jonathan Sanoff, keeps track of these things. He told me about a site called the Therapeutics Locator, which The Assistant Secretary for Preparedness and Response at The Department of Health and Human Services and her staff have prepared. The Assistant Secretary is Rear Admiral Rachel L. Levine, MD. The site tells potential patients where to find these drugs, whether they are in Puerto Rico or Alaska. For skeptics, the site also includes the number of doses on hand at each site and the total made so far, as well as information on each drug. As new therapies come online, they will appear on the Therapeutics Locator. There are currently seven drugs and monoclonal antibodies on the site. The Asst Secretary and her staff do not get much credit, but they should. See: www.covid-19-therapeutics-locator-dhhs.hub.arcgis.com/.

It is important to have many anti-viral drugs, and I was surprised to learn that 23 are still in late clinicals trials. We learned from HIV therapy that an RNA virus can develop resistance to a single drug but cannot evolve resistance to three drugs and is why the number 23 is a pleasant surprise. An even better surprise is, some of these drugs inhibit other RNA viruses, including Zika and Ebola.

Nothing in science or medicine must work, no matter how clever the idea. We should not be surprised that 26 vaccines failed, 92 treatments did not pass muster, and 54 antivirals did not inhibit SARS-CoV-2.  These results on therapies in the development pipeline have been collected by Heidi Ledford, one of Nature Magazine’s senior reporters (Nature, March 3, 2022). I am grateful to her. In that context, the March 11 issue of Science, the flagship publication of the American Academy of Sciences, contains a detailed comparison and analysis of these treatments and ideas on what we need to prepare for the next epidemic. Pandemics are too large a subject to cover everything — we have left out the value of logistics and convincing people to take vaccines, not to mention long Covid, but people are studying these challenges. The combination of basic science, private industry, and public health services have done well, although praise sounds hollow when millions have died.

What to do? Get vaccinated and boosted. When new boosters designed to attack SARS-CoV-2 or its variants appear, get those too. Even with the vaccine, you may get mild disease, but the name of the game is to prevent progress to serious disease and hospitalization. The new drugs offer reassurance. In places where the virus and infection are in decline, it is time to resume normal life.  Or at least that is my plan.

 

Richard Kessin is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center. Reach him at Richard.Kessin@gmail.com. His website contains more information: RichardKessin.com.

 

 

       

             

 

The views expressed here are not necessarily those of The Lakeville Journal and The Journal does not support or oppose candidates for public office.

Latest News

Robin Wall Kimmerer urges gratitude, reciprocity in talk at Cary Institute

Robin Wall Kimmerer inspired the audience with her grassroots initiative “Plant, Baby, Plant,” encouraging restoration, native planting and care for ecosystems.

Aly Morrissey

Robin Wall Kimmerer, the bestselling author of “Braiding Sweetgrass” and a member of the Citizen Potawatomi Nation, urged a sold-out audience at the Cary Institute of Ecosystem Studies on Friday, March 13, to rethink humanity’s relationship with the natural world through gratitude, reciprocity and responsibility.

Introduced by Cary Institute President Joshua Ginsberg, Kimmerer opened the evening by greeting the audience in Potawatomi, the native language of her ancestors, and grounding the talk in a practice of gratitude.

Keep ReadingShow less

Melissa Gamwell’s handmade touch

Melissa Gamwell’s handmade touch
Melissa Gamwell, hand lettering with precision and care.
Kevin Greenberg
"There is no better feeling than working through something with your own brain and your own hands." —Melissa Gamwell

In an age of automation, Melissa Gamwell is keeping the human hand alive.

The Cornwall, Connecticut-based calligrapher is practicing an art form that’s been under attack by machines for nearly 400 years, and people are noticing. For proof, look no further than the line leading to her candle-lit table at the Stissing House Craft Feast each winter. In her first year there, she scribed around 1,200 gift tags, cards, and hand drawn ornaments.

Keep ReadingShow less
Regional 7 students bring ‘The Addams Family’ to the stage

The cast of “The Addams Family” from Northwest Regional School District No. 7 with Principal Kelly Carroll from Ann Antolini Elementary School in New Hartford.

Monique Jaramillo

Nearly 50 students from across the region are helping bring the delightfully macabre world of “The Addams Family” to life in Northwestern Regional School District No. 7’s upcoming production. The student cast and crew, representing the towns of Barkhamsted, Colebrook, New Hartford and Norfolk, will stage the musical March 27 and 28 at 7 p.m., with a 2 p.m. matinee on March 29 in the school’s auditorium in Winsted.

Based on the iconic characters created by Charles Addams, the musical follows Wednesday Addams, who shocks her famously eccentric family by falling in love with a perfectly “normal” young man. When his parents come to dinner at the Addams’ mansion, two very different families collide, leading to an evening of secrets, surprises and unexpected revelations about love and belonging.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

‘Quilts of Many Colors’ opens at Hunt Library

Garth Kobel, Art Wall Chair, Mary Randolph, Frank Halden, Ruth Giumarro, Project Chair, Maria Bulson, Barbara Lobdell, Sherry Newman, Elizabeth Frey-Thomas, Donna Heinz around “The Green Man.”

Robin Roraback

In honor of National Quilt Day, a tradition established in 1991, Hunt Library’s second annual quilt show, “Quilts of Many Colors,” will open Saturday, March 21, with a reception from 5 to 7 p.m. The quilts, made by members of the Hunt Library Quilters, will be displayed through April 17. All quilts will be for sale, and a portion of each sale goes to the library.

At the center of the exhibit is a quilt the Hunt Library Quilters collaborated on called the “Quilt of Many Colors,” inspired by Dolly Parton’s song”Coat of Many Colors.” Each member of the Hunt Library Quilters made two to four 10-inch squares for the twin-size quilt, with Gail Allyn embroidering “The Green Man” for the center square. The Green Man, a symbol of rebirth, is also a symbol of the library, seen carved in stone at the library’s entrance. One hundred percent of the sale of this quilt benefits the library.

Keep ReadingShow less

New in at Kenise Barnes Fine Art

New in at Kenise Barnes Fine Art

New works on display at Kenise Barnes Fine Art in Kent

D.H. Callahan

Since 2018, Kenise Barnes Fine Art in Kent has been displaying an impressive rotation of works across a range of artists and mediums. On Saturday, March 14, art enthusiasts arrived to see a new exhibition at the gallery featuring a wide variety of new pieces.

Large-scale paintings by David Collins and Melanie Parke alongside small 3-by-3 inch oil-on-panel works by Sally Maca.

Keep ReadingShow less
Trailblazing divorce attorney Harriet Newman Cohen to speak at Norfolk Library

Harriet Newman Cohen

Provided

Harriet Newman Cohen weathered many storms in her five-decade-long journey to become one of the nation’s most celebrated divorce attorneys. Voted one of the top 100 attorneys in New York for many years, Cohen served as president of the New York Women’s Bar Association and has been a champion of divorce reform. She and her co-author, journalist David Feinberg, will give a book talk about her memoir, “Passion and Power: A Life in Three Worlds,” at the Norfolk Library on Sunday, March 22 at 2 p.m.

What began as a personal record of her life, intended for her family, grew into a memoir that journalist Carl Bernstein describes in his endorsement as “wise and riveting.” Born in 1932 in Providence, Rhode Island, to parents who immigrated in 1920 from Ukraine and Poland, Cohen traces the arc of her life and the challenges she faced entering a legal profession that was overwhelmingly male at the time, leading to her success as a maverick divorce attorney fighting for women’s rights and equity in the law. She received her Juris Doctor, cum laude, from Brooklyn Law School in 1974, one year after Roe v. Wade was decided. She is a founding partner of Cohen Stine Kapoor LLP in New York City, a family and matrimonial law firm she formed in 2021, at age 88, with her daughter Martha Cohen Stine and Ankit Kapoor.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.